Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission-Reference-Cited by-同舟云学术

Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission

Published:2013-09-02 Issue:1 Volume:49 Page:11-16
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kunter G,Perkins J B,Pidala J,Nishihori T,Kharfan-Dabaja M A,Field T,Fernandez H,Perez L,Locke F,Ayala E,Tomblyn M,Ochoa-Bayona J L,Betts B,Nieder M,Anasetti C

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2013121.pdf

Reference40 articles.

1. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827–1833.

2. Fielding AK, Rowe JM, Richards SM, Buck G, Moorman AV, Durrant IJ et al. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Blood 2009; 113: 4489–4496.

3. Lee HJ, Thompson JE, Wang ES, Wetzler M . Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 2011; 117: 1583–1594.

4. Mohty M, Labopin M, Volin L, Gratwohl A, Socie G, Esteve J et al. Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood 2010; 116: 4439–4443.

5. Marks DI, Wang T, Perez WS, Antin JH, Copelan E, Gale RP et al. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood 2010; 116: 366–374.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53;Cell Death & Disease;2021-05-26

2. A systematic review of outcomes after stem cell transplantation in acute lymphoblastic leukemia with or without measurable residual disease;Leukemia & Lymphoma;2020-01-21

3. Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL;Leukemia Research Reports;2018

4. Advances in adult acute lymphoblastic leukemia therapy;Leukemia & Lymphoma;2017-07-26

5. Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?;Current Hematologic Malignancy Reports;2017-02-18